2A Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.2apharma.com
A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
Phase 1
Completed
- Conditions
- Papillomavirus Infections
- Interventions
- Biological: AAVLP-HPVDrug: Placebo
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- 2A Pharma AB
- Target Recruit Count
- 20
- Registration Number
- NCT03929172
- Locations
- 🇬🇧
Celerion Inc., Belfast, Co.Antrim, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath